Insider trades
Laura Brege, Director of Mirum Pharmaceuticals MIRM, has filed 1 purchase and 7 sales on the open market. The latest trade was on 06/15.
Laura Brege
Director
- Company
- Mirum Pharmaceuticals MIRM
- First filing
- 23/01/17
- Trades
- 55 trades
- Buys / sales
- 1 / 7
- 12-month net buying
- No record
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MIRM | Open-market sale | 25/09/11 | 25/09/12 | 17,000 sh2 trades | $74.40avg. | $1,264,868.43 | −52.0% |
| Open-market sale | 25/06/04 | 25/06/05 | 14,446 sh | $21.78 | $314,633.88 | −48.9% | |
| Open-market buy | 24/08/16 | 24/08/19 | 1,000 sh | $12.81 | $12,810 | +6.0% | |
| Open-market sale10b5-1 plan | 23/06/12 | 23/06/14 | 4,500 sh | $24.87 | $111,915 | −25.0% | |
| Open-market sale10b5-1 plan | 23/06/05 | 23/06/07 | 600 sh | $38.74 | $23,244 | −5.9% | |
| Open-market sale10b5-1 plan | 23/04/03 | 23/04/05 | 7,000 sh | $40.72 | $285,040 | −40.8% | |
| Open-market sale | 23/01/12 | 23/01/17 | 12,500 sh | $18.25 | $228,125 | −100.0% |
